• Electrical Stimulation Enhances Magnetic Nanoparticle Uptake

  2026-06-25

  This study introduces alternating current (AC) electrical stimulation as a robust strategy for promoting endocytosis of magnetic nanoparticles (MNPs) across multiple cancer cell lines. The findings demonstrate substantial increases in nanoparticle uptake, with significant practical benefits for magnetic hyperthermia, MRI, and drug delivery applications.

• FK866 (APO866): Potent NAMPT Inhibitor for AML Research

  2026-06-25

  FK866 (APO866) is a nanomolar-potency, non-competitive NAMPT inhibitor that selectively depletes NAD in acute myeloid leukemia (AML) cells, sparing normal progenitors. It enables mechanistic dissection of cell death and metabolism in hematologic cancer research.

• SNAI1–PIK3R2/p-EphA2 Axis Drives EMT and Stemness in Thymic

  2026-06-24

  This study identifies SNAI1 as a central regulator of epithelial-mesenchymal transition (EMT) and cancer stem cell-like properties in thymic epithelial tumors (TETs) via the PIK3R2/p-EphA2 pathway. By integrating multi-omics, single-cell, and functional assays, the research uncovers actionable molecular mechanisms that could inform new therapeutic approaches targeting SNAI1 in TETs.

• SNAI1 Drives EMT and Stemness in Thymic Tumors via PIK3R2/p-

  2026-06-23

  This study delineates how SNAI1 functions as a hub transcription factor promoting epithelial-mesenchymal transition (EMT) and maintaining cancer stem cell-like properties in thymic epithelial tumors (TETs) through the PIK3R2/p-EphA2 signaling axis. The comprehensive multi-omics approach provides mechanistic clarity and suggests new molecular targets for future therapeutic strategies in rare thymic malignancies.

• Ceramides Facilitate Pro-viral Autophagy in Fish Nodavirus I

  2026-06-23

  This study leverages global lipidomics to reveal how red-spotted grouper nervous necrosis virus (RGNNV) manipulates ceramide metabolism to promote its replication. By demonstrating that ceramide accumulation drives pro-viral autophagy, the research highlights new antiviral targets and deepens our understanding of host-virus lipid interactions in aquatic disease.

• Baicalein: Mechanistic Insights and Translational Impact in

  2026-06-22

  Explore the mechanistic depth of Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) as a research compound in cancer cell proliferation inhibition and inflammation pathway modulation. This article offers an advanced, comparative perspective distinct from standard protocol guides.

• Elobixibat Hydrate: Translating Bile Acid Transport Inhibiti

  2026-06-22

  This thought-leadership article explores Elobixibat hydrate's role as a selective ileal bile acid transporter inhibitor, dissecting its molecular mechanism, clinical leverage in chronic idiopathic constipation and type 2 diabetes, and emerging research frontiers. Integrating recent literature and protocol guidance, we chart strategic directions for translational researchers, while positioning APExBIO’s Elobixibat hydrate as a benchmark tool for advancing gastrointestinal and metabolic disease modeling.

• Decoding Calcium-Driven Apoptosis: BAPTA in Translational To

  2026-06-21

  This thought-leadership article explores the mechanistic role of BAPTA, a high-affinity calcium chelator, in dissecting IP3R/Ca2+/STAT3-mediated apoptosis during co-exposure to nanoplastics and cadmium. It synthesizes recent evidence, offers actionable guidance for translational researchers, and positions BAPTA from APExBIO as a pivotal tool for advanced cell signaling studies in environmental toxicology.

• Aconitase Activity Colorimetric Assay Kit in Immunometabolis

  2026-06-20

  Transform mitochondrial research and oxidative stress analysis with the Aconitase Activity Colorimetric Assay Kit. This high-throughput tool delivers rapid, quantitative insights into TCA cycle enzyme function, enabling robust, reproducible workflows for advanced immunometabolic studies.

• AZD6482: Precision PI3Kβ Inhibitor for Translational Workflo

  2026-06-19

  AZD6482 offers targeted, ATP-competitive inhibition of PI3Kβ, enabling researchers to dissect the PI3K/Akt/mTOR pathway with exceptional selectivity. This article translates cutting-edge research and advanced assay strategies into actionable workflows, troubleshooting guidance, and comparative applications for maximizing the impact of AZD6482 in disease modeling and anti-thrombotic research.

• Ciprofloxacin (hydrochloride): Scenario-Driven Lab Solutions

  2026-06-19

  This article delivers a practical, scenario-based guide to optimizing cell viability and antibacterial assays using Ciprofloxacin (hydrochloride) (SKU C5539). Drawing on peer-reviewed evidence and real-world workflow challenges, we illustrate how APExBIO’s high-purity formulation supports reproducible, data-driven research for biomedical scientists and technicians.

• Optimizing Cell Assays with SNS-032 (BMS-387032): Practical

  2026-06-18

  This article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how SNS-032 (BMS-387032) (SKU A1980) provides reproducible, data-driven solutions. Drawing from published literature and product specifications, we explore real-world scenarios, protocol parameters, and vendor selection strategies for biomedical researchers seeking reliable results.

• (S)-(+)-Ibuprofen: Advanced Mechanistic Insights for COX Inh

  2026-06-18

  (S)-(+)-Ibuprofen stands as a gold-standard COX inhibitor, pivotal for inflammation pathway research. This article offers a uniquely in-depth analysis of its mechanistic profile and practical assay implications, with new insights on synthesis and selectivity.

• Triiodothyronine (T3) in Metabolic Assays: Workflow Innovati

  2026-06-17

  Triiodothyronine (T3) from APExBIO enables high-fidelity modeling of thyroid hormone signaling and metabolic regulation in cellular and animal systems. Leveraging recent mechanistic insights into β-catenin–mediated thermogenesis, this guide details protocol enhancements, troubleshooting strategies, and advanced assay designs for robust and reproducible results.

• UK-5099: Strategic Use in Immunometabolism and Translational

  2026-06-17

  This thought-leadership article unveils how UK-5099 (PF-1005023), a potent mitochondrial pyruvate carrier inhibitor, enables translational researchers to dissect and modulate immunometabolic pathways with mechanistic precision. Drawing on standardized whole-blood stimulation protocols and recent advances in immunometabolism, the article delivers practical guidance, competitive insights, and an outlook on the evolving landscape of metabolic intervention in immune research.

16235 records 1/1083 page Next 12345 下5页 Last page